Isik Cansu Mercan, Bayyurt Elif Burcu Tuzemen, Sahin Nil Ozbilum
Department of Child and Adolescent Psychiatry, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey.
Department of Medical Biology, Faculty of Medicine, Cumhuriyet University, 58140, Sivas, Turkey.
Eur J Pediatr. 2025 Mar 19;184(4):260. doi: 10.1007/s00431-025-06089-6.
Specific learning disorder (SLD) is a neurodevelopmental disorder that significantly affects children's academic performance. This study aimed to investigate the expression levels of the MAP Kinase Interacting Serine/Threonine Kinase 1-2 (MNK1, MNK2), Synaptic Ras GTPase Activating Protein 1 (SYNGAP1) genes, and the long non-coding RNA Synaptic Ras GTPase Activating Protein 1-Anti Sense1 (SYNGAP1-AS1), which are believed to play a key role in neurodevelopmental pathways, in children with SLD. Understanding the role of these genes in synaptic plasticity and cognitive function may provide insights into the molecular mechanisms underlying SLD. This study included 38 children diagnosed with SLD and 35 healthy controls aged 6 to 16. RNA was isolated from blood samples, and gene expression levels were measured using quantitative polymerase chain reaction (qPCR). The statistical analysis was conducted to compare the expression levels between the SLD and control groups and within SLD subgroups based on severity and sex. MNK1 and SYNGAP1 expression levels were significantly upregulated in the SLD group compared to the control group (8.33-fold and 16.52-fold increase, respectively; p < 0.001). lncSYNGAP1-AS1 showed a 26.58-fold increase, while MNK2 was downregulated by 2.2-fold, although these changes were not statistically significant. No significant differences were observed between sexes or between the severity subgroups of SLD.
he upregulation of MNK1 and SYNGAP1 in children with SLD suggests their involvement in the neurodevelopmental pathways associated with cognitive processes such as learning and memory. These findings provide a foundation for future research into the molecular basis and potential therapeutic targets of SLD.
• SYNGAP1 is a key regulator of synaptic plasticity and learning, primarily functioning through Ras signaling inhibition. Its deficiency impairs long-term potentiation (LTP) and is associated with neurodevelopmental disorders (NDDs) such as autism spectrum disorder (ASD) and intellectual disability. • The MAPK/ERK pathway plays a crucial role in learning and memory, and its dysregulation has been linked to several neurological conditions. MNK1/2 interacts with SYNGAP1 in synaptic signaling.
• This study is the first to demonstrate significant upregulation of SYNGAP1 and MKNK1 in children with SLD. • Understanding the role of the MKNK-SYNGAP1 axis may guide the development of targeted therapies aimed at enhancing synaptic plasticity to improve learning and memory outcomes in children with SLD.
特定学习障碍(SLD)是一种神经发育障碍,严重影响儿童的学业成绩。本研究旨在调查丝裂原活化蛋白激酶相互作用丝氨酸/苏氨酸激酶1-2(MNK1、MNK2)、突触Ras GTP酶激活蛋白1(SYNGAP1)基因以及长链非编码RNA突触Ras GTP酶激活蛋白1反义链1(SYNGAP1-AS1)的表达水平,这些基因被认为在神经发育途径中起关键作用,研究对象为患有SLD的儿童。了解这些基因在突触可塑性和认知功能中的作用,可能有助于深入了解SLD潜在的分子机制。本研究纳入了38名诊断为SLD的儿童和35名年龄在6至16岁的健康对照。从血液样本中提取RNA,并使用定量聚合酶链反应(qPCR)测量基因表达水平。进行统计分析以比较SLD组和对照组之间以及基于严重程度和性别的SLD亚组内的表达水平。与对照组相比,SLD组中MNK1和SYNGAP1的表达水平显著上调(分别增加8.33倍和16.52倍;p<0.001)。lncSYNGAP1-AS1增加了26.58倍,而MNK2下调了2.2倍,尽管这些变化无统计学意义。在性别之间或SLD的严重程度亚组之间未观察到显著差异。
SLD儿童中MNK1和SYNGAP1的上调表明它们参与了与学习和记忆等认知过程相关的神经发育途径。这些发现为未来研究SLD的分子基础和潜在治疗靶点奠定了基础。
• SYNGAP1是突触可塑性和学习的关键调节因子,主要通过抑制Ras信号发挥作用。其缺陷会损害长时程增强(LTP),并与自闭症谱系障碍(ASD)和智力障碍等神经发育障碍(NDDs)相关。• MAPK/ERK途径在学习和记忆中起关键作用,其失调与多种神经系统疾病有关。MNK1/2在突触信号传导中与SYNGAP1相互作用。
• 本研究首次证明SLD儿童中SYNGAP1和MKNK1显著上调。• 了解MKNK-SYNGAP1轴的作用可能会指导开发旨在增强突触可塑性以改善SLD儿童学习和记忆结果的靶向治疗方法。